Concepts (119)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Toll-Like Receptors | 2 | 2011 | 586 | 0.590 |
Why?
|
| Agammaglobulinemia | 1 | 2014 | 171 | 0.420 |
Why?
|
| Ligands | 2 | 2011 | 3266 | 0.280 |
Why?
|
| Lipopolysaccharides | 2 | 2011 | 2192 | 0.280 |
Why?
|
| Killer Cells, Natural | 1 | 2014 | 2170 | 0.250 |
Why?
|
| Homeodomain Proteins | 1 | 2014 | 2399 | 0.240 |
Why?
|
| Communicable Disease Control | 1 | 2011 | 841 | 0.240 |
Why?
|
| rac1 GTP-Binding Protein | 2 | 2017 | 241 | 0.240 |
Why?
|
| Myocytes, Cardiac | 1 | 2010 | 1611 | 0.200 |
Why?
|
| B-Lymphocytes | 1 | 2014 | 4671 | 0.190 |
Why?
|
| Polymorphism, Single Nucleotide | 6 | 2019 | 15366 | 0.180 |
Why?
|
| Iran | 6 | 2019 | 708 | 0.160 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2019 | 73 | 0.160 |
Why?
|
| T-Lymphocytes | 3 | 2016 | 10018 | 0.160 |
Why?
|
| Heart Failure | 4 | 2019 | 11089 | 0.150 |
Why?
|
| Wiskott-Aldrich Syndrome Protein | 1 | 2016 | 160 | 0.130 |
Why?
|
| Cytokines | 1 | 2010 | 7219 | 0.130 |
Why?
|
| Guanine Nucleotide Exchange Factors | 2 | 2016 | 563 | 0.120 |
Why?
|
| Virus Diseases | 2 | 2011 | 722 | 0.120 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2011 | 1822 | 0.110 |
Why?
|
| Interleukin-10 | 1 | 2019 | 1156 | 0.110 |
Why?
|
| Receptors, Interleukin | 1 | 2015 | 243 | 0.110 |
Why?
|
| Colitis, Ulcerative | 2 | 2017 | 1899 | 0.110 |
Why?
|
| Interleukin-23 | 1 | 2014 | 191 | 0.100 |
Why?
|
| Lymphocyte Depletion | 1 | 2014 | 588 | 0.100 |
Why?
|
| Interleukin-17 | 1 | 2018 | 891 | 0.100 |
Why?
|
| Th17 Cells | 1 | 2018 | 768 | 0.100 |
Why?
|
| Crohn Disease | 2 | 2015 | 2243 | 0.100 |
Why?
|
| Signal Transduction | 3 | 2011 | 23112 | 0.100 |
Why?
|
| Opportunistic Infections | 1 | 2014 | 376 | 0.100 |
Why?
|
| Gene Expression Regulation | 2 | 2019 | 11839 | 0.090 |
Why?
|
| DNA | 2 | 2014 | 7199 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2017 | 17434 | 0.080 |
Why?
|
| Homozygote | 1 | 2014 | 1767 | 0.080 |
Why?
|
| Fatal Outcome | 1 | 2014 | 1825 | 0.080 |
Why?
|
| Interleukin-4 | 1 | 2013 | 1101 | 0.080 |
Why?
|
| Interleukin-18 | 1 | 2010 | 241 | 0.080 |
Why?
|
| Early Diagnosis | 1 | 2014 | 1174 | 0.080 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2012 | 261 | 0.080 |
Why?
|
| Lipoproteins, LDL | 1 | 2011 | 635 | 0.070 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2016 | 2511 | 0.070 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2011 | 551 | 0.070 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2010 | 568 | 0.070 |
Why?
|
| Interleukin-1 | 1 | 2010 | 1251 | 0.070 |
Why?
|
| Chronic Disease | 4 | 2019 | 9116 | 0.070 |
Why?
|
| Pedigree | 1 | 2014 | 4555 | 0.070 |
Why?
|
| Genome | 1 | 2014 | 1744 | 0.070 |
Why?
|
| Interleukin-6 | 2 | 2018 | 3153 | 0.070 |
Why?
|
| Adjuvants, Immunologic | 1 | 2010 | 1026 | 0.060 |
Why?
|
| Genotype | 5 | 2019 | 12773 | 0.060 |
Why?
|
| Case-Control Studies | 6 | 2019 | 21673 | 0.060 |
Why?
|
| Carrier Proteins | 1 | 2016 | 4926 | 0.050 |
Why?
|
| Vaccines | 1 | 2011 | 817 | 0.050 |
Why?
|
| Polymorphism, Genetic | 1 | 2013 | 4275 | 0.050 |
Why?
|
| Myocardial Ischemia | 1 | 2013 | 2142 | 0.050 |
Why?
|
| Phytohemagglutinins | 2 | 2011 | 167 | 0.050 |
Why?
|
| Hypersensitivity | 1 | 2010 | 1134 | 0.050 |
Why?
|
| Coronary Artery Disease | 2 | 2011 | 6454 | 0.050 |
Why?
|
| Genetic Testing | 1 | 2014 | 3477 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2010 | 4335 | 0.040 |
Why?
|
| Autoimmune Diseases | 1 | 2010 | 2193 | 0.040 |
Why?
|
| Disease Progression | 1 | 2014 | 13303 | 0.040 |
Why?
|
| Humans | 17 | 2019 | 746044 | 0.040 |
Why?
|
| Gene Frequency | 2 | 2014 | 3532 | 0.030 |
Why?
|
| Immunological Synapses | 1 | 2016 | 53 | 0.030 |
Why?
|
| Animals | 4 | 2016 | 166331 | 0.030 |
Why?
|
| Lymphocyte Count | 1 | 2018 | 775 | 0.030 |
Why?
|
| Hospitals, University | 1 | 2017 | 566 | 0.030 |
Why?
|
| Atherosclerosis | 1 | 2011 | 3417 | 0.030 |
Why?
|
| Alleles | 2 | 2017 | 6831 | 0.030 |
Why?
|
| Immunotherapy | 1 | 2010 | 4594 | 0.030 |
Why?
|
| Apoptosis | 1 | 2010 | 9421 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2019 | 3426 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2019 | 2593 | 0.030 |
Why?
|
| Mutation | 2 | 2014 | 29614 | 0.030 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2018 | 2584 | 0.030 |
Why?
|
| Infant | 1 | 2014 | 35444 | 0.030 |
Why?
|
| Reference Values | 1 | 2019 | 4875 | 0.020 |
Why?
|
| Neoplasms | 2 | 2011 | 21688 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2014 | 41376 | 0.020 |
Why?
|
| Male | 8 | 2019 | 351093 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2016 | 965 | 0.020 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2016 | 529 | 0.020 |
Why?
|
| Epidermodysplasia Verruciformis | 1 | 2011 | 22 | 0.020 |
Why?
|
| Warts | 1 | 2011 | 66 | 0.020 |
Why?
|
| Cytoskeletal Proteins | 1 | 2016 | 1348 | 0.020 |
Why?
|
| Protein Transport | 1 | 2016 | 1960 | 0.020 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2012 | 249 | 0.020 |
Why?
|
| Solubility | 1 | 2011 | 1088 | 0.020 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2011 | 532 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2016 | 4178 | 0.020 |
Why?
|
| Immunity, Humoral | 1 | 2011 | 574 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2019 | 9596 | 0.020 |
Why?
|
| Haplotypes | 1 | 2013 | 2722 | 0.020 |
Why?
|
| Child | 1 | 2014 | 78456 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2016 | 2881 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2011 | 18891 | 0.020 |
Why?
|
| Cell Proliferation | 2 | 2011 | 10300 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2016 | 3448 | 0.020 |
Why?
|
| Female | 7 | 2019 | 382109 | 0.010 |
Why?
|
| Cell Movement | 1 | 2016 | 5162 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 2011 | 1760 | 0.010 |
Why?
|
| Protein Binding | 1 | 2016 | 9278 | 0.010 |
Why?
|
| Middle Aged | 5 | 2019 | 214412 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2013 | 6058 | 0.010 |
Why?
|
| Interleukin-2 | 1 | 2010 | 1868 | 0.010 |
Why?
|
| Adult | 5 | 2017 | 214958 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2011 | 2416 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 15537 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2016 | 14211 | 0.010 |
Why?
|
| Family | 1 | 2012 | 3156 | 0.010 |
Why?
|
| Cell Survival | 1 | 2011 | 5761 | 0.010 |
Why?
|
| Phenotype | 1 | 2017 | 16245 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2011 | 10718 | 0.010 |
Why?
|
| Prognosis | 1 | 2019 | 29068 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 21529 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2018 | 53218 | 0.010 |
Why?
|
| Aged | 2 | 2019 | 164236 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2012 | 63661 | 0.000 |
Why?
|
Concepts
(119)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(4)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_